Lifecycle Management for Recombinant Protein Production Using Mammalian Cell Culture Technology

被引:1
|
作者
Moran, Enda [1 ]
Gammell, Patrick [1 ]
机构
[1] Pfizer, BioMfg Sci, Dublin 22, Ireland
关键词
Cell culture technology; Post-approval changes; Technology lifecycle management;
D O I
10.1007/10_2013_258
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Product lifecycle management refers to the oversight process and activities carried out to fully realize the commercial potential and value of a product in the marketplace. It is typical for many changes to be introduced to the production processes and testing methods for biopharmaceutical drugs over their lifetime in the commercial marketplace. Technology lifecycle management, as discussed here, refers to the management of the different phases or generations of processes and methods used to make and test the active biopharmaceutical ingredient or drug product, and the adoption of different devices used to present the drug product to patients. The factors to consider when making changes to a commercial biopharmaceutical manufacturing process as part of a technology lifecycle management program are discussed. A case study outlines one approach taken in bringing forward a major process change to a cell culture process for the production of a therapeutic recombinant protein.
引用
收藏
页码:245 / 256
页数:12
相关论文
共 50 条
  • [11] Recombinant protein production from stable mammalian cell lines and pools
    Hacker, David L.
    Balasubramanian, Sowmya
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 2016, 38 : 129 - 136
  • [12] Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
    Lai, Tingfeng
    Yang, Yuansheng
    Ng, Say Kong
    PHARMACEUTICALS, 2013, 6 (05): : 579 - 603
  • [13] Mammalian cell culture for production of recombinant proteins: A review of the critical steps in their biomanufacturing
    O'Flaherty, Roisin
    Bergin, Adam
    Flampouri, Evangelia
    Mota, Leticia Martins
    Obaidi, Ismael
    Quigley, Andrew
    Xie, Yongjing
    Butler, Michael
    BIOTECHNOLOGY ADVANCES, 2020, 43
  • [14] Production of the human β-interferon recombinant protein in avian cell culture
    E. A. Cherentaeva
    D. Yu. Logunov
    L. V. Verkhovskaya
    M. V. Mezentseva
    M. M. Shmarov
    F. I. Ershov
    B. S. Naroditskii
    A. L. Gintsburg
    Molecular Genetics, Microbiology and Virology, 2008, 23 : 153 - 157
  • [15] Production of the Human β-Interferon Recombinant Protein in Avian Cell Culture
    Cherentaeva, E. A.
    Logunov, D. Yu.
    Verkhovskaya, L. V.
    Mezentseva, M. V.
    Shmarov, M. M.
    Ershov, F. I.
    Naroditskii, B. S.
    Gintsburg, A. L.
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2008, 23 (03) : 153 - 157
  • [16] The effect of immobilization on recombinant protein production in plant cell culture
    Bodeutsch T.
    James E.A.
    Lee J.M.
    Plant Cell Reports, 2001, 20 (06) : 562 - 566
  • [17] Transient gene expression: A novel mammalian cell-based technology for recombinant protein production - A historical and technical perspective
    Wurm, FM
    Baldi, L
    Girard, JP
    Lindell, J
    Grosjean, F
    Muller, N
    Jacquet, R
    Wright, J
    Mason, A
    Hacker, D
    Dejesus, M
    Picasso, S
    Batard, P
    Jordan, M
    ANIMAL CELL TECHNOLOGY: BASIC & APPLIED ASPECTS, VOL 13, 2003, : 83 - 88
  • [18] Chromatin-modifying elements for recombinant protein production in mammalian cell systems
    Guo, Xiao
    Wang, Chong
    Wang, Tian-Yun
    CRITICAL REVIEWS IN BIOTECHNOLOGY, 2020, 40 (07) : 1035 - 1043
  • [19] PRODUCTION OF RECOMBINANT FACTOR-VIII (KOGENATETM) FROM MAMMALIAN-CELL CULTURE
    BODEKER, BG
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 705 - 705
  • [20] The enhancement of recombinant protein production by polymer nanospheres in cell suspension culture
    Ryu, JH
    Kim, MS
    Lee, GM
    Choi, CY
    Kim, BS
    BIOMATERIALS, 2005, 26 (14) : 2173 - 2181